Binicell

Binicell is a South Korean biotechnology company specializing in the development of exosome-based precision medicine and targeted therapeutics. The company utilizes its proprietary Exo-Isolator technology to achieve high-purity isolation of extracellular vesicles from various biological fluids, addressing a major bottleneck in the field. This platform supports two primary business pillars: high-sensitivity liquid biopsy diagnostics for early cancer detection and the engineering of exosomes as biocompatible drug delivery vehicles. Binicell's therapeutic pipeline focuses on oncology and inflammatory diseases, aiming to deliver potent payloads directly to diseased cells while minimizing systemic side effects. By integrating advanced microfluidics with molecular biology, the company is positioning itself as a leader in the rapidly evolving exosome research space.